跳至主要内容
临床试验/NCT06918873
NCT06918873招募中不适用

Quality of Life During Different Regimens of Combined Hormonal Contraceptives in Women of Reproductive Age

Fondazione IRCCS Policlinico San Matteo di Pavia1 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2014年5月5日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
400
试验地点
1
主要终点
Impact of different estrogen-progestin contraception regimens on sexual function and sexually related distress.

研究概览

简要总结

The aim of the present study is to investigate the psychosexual effects of combined hormonal contraception regimens, comparing them in terms of estrogen type and dosage, hormonal combination regimen and different routes of administration, in women seeking a hormonal contraception method to prevent unwanted pregnancies. In particular, the study focuses on the incidence of mood disorders and sexual dysfunctions associated with distress in the entire study population using combined hormonal contraception. It will also examine the incidence of these conditions under the influence of specific combined hormonal contraceptives, as well as whether different types of progestins and the route of administration (oral, vaginal or transdermal) may affect the occurrence of mood disorders and sexual dysfunctions.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •women of childbearing age (aged 18-40) who seek advice for use of combined hormonal contraception (CHC).
  • •stable relationship

排除标准

  • 未提供

结局指标

主要结局

Impact of different estrogen-progestin contraception regimens on sexual function and sexually related distress.

时间窗: 6 months

Evaluate the trend of the scores of the Female Sexual Function Index (FSFI) in the entire study population using combined hormonal contraception (CHC), both at baseline and after 6 months of CHC exposure; evaluate whether the FSFI scores vary significantly in relation to the type and dosage of estrogen used in hormonal contraception; evaluate the extent of female sexual distress score (FSDS) in the entire study population using CHC, both at baseline and after 6 months of CHC exposure; evaluate whether the FSDS scores vary significantly in relation to the type and dosage of estrogen used in hormonal contraception.

次要结局

  • Impact of combined hormonal contraception on mood disorders(6 months)
  • Impact of basal clinical variables mood disorders and sexual dysfunction in women using combined hormonal contraception(6 months)

研究者

发起方
Fondazione IRCCS Policlinico San Matteo di Pavia
申办方类型
Other
责任方
Principal Investigator
主要研究者

Rossella Nappi

Principal Investigator

Fondazione IRCCS Policlinico San Matteo di Pavia

研究点 (1)

Loading locations...

相似试验